Annual CAPEX
N/A
31 December 2023
Summary:
Lumos Pharma annual capital expenditures is not available.LUMO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Lumos Pharma quarterly capital expenditures is not available.LUMO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Lumos Pharma TTM capital expenditures is not available.LUMO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
LUMO CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Lumos Pharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $21.00 K(-30.0%) | - | - |
| Dec 2021 | $30.00 K(0.0%) | - | - |
| Dec 2020 | $30.00 K(+1400.0%) | $12.00 K(+200.0%) | $30.00 K(+66.7%) |
| Sept 2020 | - | $4000.00(-71.4%) | $18.00 K(+28.6%) |
| June 2020 | - | $14.00 K(>+9900.0%) | $14.00 K(+100.0%) |
| Dec 2019 | $2000.00(-71.4%) | - | - |
| Dec 2018 | $7000.00(-83.7%) | $0.00(0.0%) | $7000.00(0.0%) |
| Sept 2018 | - | $0.00(-100.0%) | $7000.00(-200.0%) |
| June 2018 | - | $7000.00(>+9900.0%) | -$7000.00(-116.3%) |
| Dec 2017 | $43.00 K(-98.1%) | $0.00(-100.0%) | $43.00 K(-80.5%) |
| Sept 2017 | - | -$14.00 K(-163.6%) | $220.00 K(-31.0%) |
| June 2017 | - | $22.00 K(-37.1%) | $319.00 K(-84.0%) |
| Mar 2017 | - | $35.00 K(-80.2%) | $2.00 M(-11.0%) |
| Dec 2016 | $2.25 M(-43.8%) | $177.00 K(+108.2%) | $2.25 M(-14.1%) |
| Sept 2016 | - | $85.00 K(-95.0%) | $2.61 M(-31.3%) |
| June 2016 | - | $1.70 M(+506.0%) | $3.81 M(+7.4%) |
| Mar 2016 | - | $281.00 K(-48.4%) | $3.54 M(-11.3%) |
| Dec 2015 | $4.00 M | $545.00 K(-57.3%) | $4.00 M(+5.0%) |
| Sept 2015 | - | $1.28 M(-11.3%) | $3.81 M(+6.4%) |
| June 2015 | - | $1.44 M(+96.5%) | $3.58 M(+52.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $733.00 K(+105.9%) | $2.34 M(+37.6%) |
| Dec 2014 | $1.70 M(+22.7%) | $356.00 K(-66.0%) | $1.70 M(+17.2%) |
| Sept 2014 | - | $1.05 M(+413.2%) | $1.45 M(+2.9%) |
| June 2014 | - | $204.00 K(+119.4%) | $1.41 M(-0.6%) |
| Mar 2014 | - | $93.00 K(-12.3%) | $1.42 M(+2.2%) |
| Dec 2013 | $1.39 M(+4.8%) | $106.00 K(-89.5%) | $1.39 M(-5.5%) |
| Sept 2013 | - | $1.01 M(+374.5%) | $1.47 M(+203.5%) |
| June 2013 | - | $212.00 K(+241.9%) | $483.00 K(-28.6%) |
| Mar 2013 | - | $62.00 K(-66.7%) | $676.00 K(-48.9%) |
| Dec 2012 | $1.32 M(+370.8%) | $186.00 K(+708.7%) | $1.32 M(-0.1%) |
| Sept 2012 | - | $23.00 K(-94.3%) | $1.32 M(-1.3%) |
| June 2012 | - | $405.00 K(-42.9%) | $1.34 M(+42.4%) |
| Mar 2012 | - | $709.00 K(+279.1%) | $942.00 K(+235.2%) |
| Dec 2011 | $281.00 K(-90.4%) | $187.00 K(+367.5%) | $281.00 K(+198.9%) |
| Sept 2011 | - | $40.00 K(+566.7%) | $94.00 K(+74.1%) |
| June 2011 | - | $6000.00(-87.5%) | $54.00 K(+12.5%) |
| Mar 2011 | - | $48.00 K | $48.00 K |
| Dec 2010 | $2.93 M(+109.0%) | - | - |
| Dec 2009 | $1.40 M(+228.6%) | - | - |
| Dec 2008 | $427.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for Lumos Pharma?
- What is the all time high quarterly CAPEX for Lumos Pharma?
- What is the all time high TTM CAPEX for Lumos Pharma?
What is the all time high annual CAPEX for Lumos Pharma?
Lumos Pharma all-time high annual capital expenditures is $4.00 M
What is the all time high quarterly CAPEX for Lumos Pharma?
Lumos Pharma all-time high quarterly capital expenditures is $1.70 M
What is the all time high TTM CAPEX for Lumos Pharma?
Lumos Pharma all-time high TTM capital expenditures is $4.00 M